ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 73 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | -82.3% | 65,333 | +41.5% | 0.00% | – |
| Q1 2021 | $79,000 | -38.8% | 46,180 | -56.7% | 0.00% | -100.0% |
| Q2 2020 | $129,000 | +143.4% | 106,580 | +321.6% | 0.00% | – |
| Q4 2019 | $53,000 | -78.6% | 25,280 | -64.5% | 0.00% | -100.0% |
| Q1 2019 | $248,000 | -80.8% | 71,144 | -87.3% | 0.00% | -80.0% |
| Q4 2018 | $1,292,000 | +452.1% | 559,408 | +820.9% | 0.01% | +400.0% |
| Q3 2018 | $234,000 | +588.2% | 60,744 | +455.6% | 0.00% | – |
| Q1 2016 | $34,000 | -79.3% | 10,934 | -74.3% | 0.00% | -100.0% |
| Q4 2015 | $164,000 | -72.7% | 42,531 | -14.9% | 0.00% | -66.7% |
| Q1 2014 | $600,000 | – | 49,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 62,000 | $216,000 | 0.20% |
| Monashee Investment Management LLC | 187,190 | $651,000 | 0.15% |
| Cedar Wealth Management, LLC | 46,395 | $161,000 | 0.10% |
| BCWM, LLC | 35,100 | $122,000 | 0.06% |
| Tibra Equities Europe Ltd | 149,595 | $521,000 | 0.05% |
| Ahrens Investment Partners LLC | 30,900 | $108,000 | 0.05% |
| ExodusPoint Capital Management, LP | 151,904 | $529,000 | 0.04% |
| Laurion Capital Management LP | 833,400 | $2,900,000 | 0.04% |
| Alpine Global Management, LLC | 33,928 | $118,000 | 0.03% |
| Cornerstone Capital, Inc. | 57,550 | $200,000 | 0.03% |